This is the authors' abstract. We don't add key points for this paper.
Description KIR3DS1+ NK cells execute enhanced killing of adenovirus-infected cells, providing protection against severe infection in immunocompromised hosts. Armor against adenovirus Reactivation of human adenovirus (HAdV) is a major cause of mortality in children and immunocompromised individuals after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Effective therapies for severe HAdV infections are lacking; therefore, new treatment strategies are required. Using a 3D intestinal organoid system, Jung et al. investigated how natural killer (NK) cells recognize and kill HAdV-infected intestinal epithelial cells. HAdV-infected intestinal epithelial cells strongly up-regulated HLA-F, the ligand for activating NK cell receptor KIR3DS1, which enabled enhanced recognition and killing by NK cells. Furthermore, HAdV-infected pediatric allo-HSCT recipients who received KIR3DS1+/HLA-Bw4+ donor cells exhibited protection from severe HAdV infection and faster HAdV clearance. These findings suggest that the KIR3DS1/HLA-F axis is a promising target for treatment of severe HAdV reactivation after allo-HSCT. Human adenoviruses (HAdVs) are a major cause for disease in children, in particular after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Currently, effective therapies for HAdV infections in immunocompromised hosts are lacking. To decipher immune recognition of HAdV infection and determine new targets for immune-mediated control, we used an HAdV infection 3D organoid system, based on primary human intestinal epithelial cells. HLA-F, the functional ligand for the activating NK cell receptor KIR3DS1, was strongly up-regulated and enabled enhanced killing of HAdV5-infected cells in organoids by KIR3DS1+ NK cells. In contrast, HLA-A and HLA-B were significantly down-regulated in HAdV5-infected organoids in response to adenoviral E3/glycoprotein19K, consistent with evasion from CD8+ T cells. Immunogenetic analyses in a pediatric allo-HSCT cohort showed a reduced risk to develop severe HAdV disease and faster clearance of HAdV viremia in children receiving KIR3DS1+/HLA-Bw4+ donor cells compared with children receiving non–KIR3DS1+/HLA-Bw4+ cells. These findings identify the KIR3DS1/HLA-F axis as a new target for immunotherapeutic strategies against severe HAdV disease.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: